Lanean...
Treatment duration affects cytoprotective efficacy of positive allosteric modulation of α7nAChRs after focal ischemia in rats.
To minimize irreversible brain injury after acute ischemic stroke (AIS), the time to treatment (i.e., treatment delay) should be minimized. However, thus far, all cytoprotective clinical trials have failed. Analysis of literature identified short treatment durations (≤72 h) as a common motif among c...
Gorde:
| Argitaratua izan da: | Pharmacol Res |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6218269/ https://ncbi.nlm.nih.gov/pubmed/30205140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2018.09.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|